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mechaniDear Sir,
With great interest we have read the innovative study by Arslan
et al. [1], which evaluates the adhesion prevention of the lovastatin
and Sepraﬁlm barriers. This study triggered some reﬂections.
Theauthorsassume that theadhesionprevention impactof statins
is related with their anti-inﬂammatory, antioxidant and antiﬁbrotic
properties [1]. In addition, they highlighted the pro-ﬁbrinolytic
impact of statins with increased activity of tissue type plasminogen
activator (tPA) and down regulation of plasminogen activator
inhibitor-1 (PAI-1) production by humanmesothelial cells [2].
We fully agree with the authors' hypothesis of the supposed
mechanisms of the adhesion prevention impact of statins [1],
and we would like to extend the discussion and introduce our
own concept about personalized postsurgical adhesion prevention
strategy (Fig. 1) which takes into account possible predisposing
(underlying coexisting) factors which might change postsurgical
acute inﬂammation and wound healing features causing adhesion
formation. Since an initial report concerning an experimental
study aimed to investigate the effect of statins on postoperative
adhesion formation [2] was followed by an editorial article in
‘Ann Surg’ by van der Wal and Jeekel [3], which discussed both
possible beneﬁts of statins as adhesion prevention medication
and also possible harms of this medication due to well-
recognized side effects of statins such as their myotoxicity and
impairing liver and renal function. However, van der Wal and Jee-
kel [3]concluded that “this way of postoperative adhesion preven-
tion is new and refreshing by interfering with the primary
mechanism of adhesion formation”..2013.11.010.
by Elsevier Ltd. All rights reservedxample of a possible primary predisposing metabolic
sm of postsurgical complications may be a hyperhomo-
cysteinemia, or/and deﬁciency of vitamin B12, B2 and folic acid,
which promotes nitrous oxide (N2O) anesthesia-induced postsur-
gical cardiovascular complications including a cardiac infarction
[4e6]. Even a single exposure of N2O during surgery as anesthetic
medication could initiate postsurgical complications via an irre-
versible interaction of N2O with vitamin B12. This interaction
with changes in the cobalamin/methionine synthase and homo-
cysteine metabolism may be fatal for individuals with predispos-
ing genetic factors and is associated with neurotoxic, genotoxic
(increased DNA damage) effects, endothelial dysfunction with
elevated procoagulant status and increased risk of thromboembo-
lism, atherosclerosis and cardiovascular diseases [4e8]. Subse-
quently, we recently reviewed the mechanisms [9] of a
predisposing risk factor of increased postsurgical adhesion forma-
tion in a case of hyperhomocysteinemia through increased
collagen formation between adhesion ﬁbroblasts due to an
elevated cysteine concentration [4e6] and by shift of the vascular
endothelium surface from an anti- to pro-coagulant status, the
reactivation of blood platelets, alterations of several intrinsic and
extrinsic targets in the coagulation and ﬁbrinolysis system with
modiﬁcation of the blood clot/ﬁbrin clot structure with increased
resistance of ﬁbrin clot to ﬁbrinolysis [7].
It is well known that peritoneal adhesions are initiated by surgi-
cal trauma and even after similar surgical procedures different out-
comes can be found concerning postsurgical adhesions. Some
individuals may have extended and severe postsurgical adhesions
followed by complications which require repeated interventions,
while others might not have any adhesions. The application of state
of the art technologies has shown that some genetic and constitu-
tional factors are associated with an increased susceptibility to
postoperative adhesion formation.
Hence, we presume that there are predisposing genetic and
constitutional conditions, which could change the character of dy-
namic postsurgical acute inﬂammation and wound healing mecha-
nisms and play the role of coexisting factors, activating or inhibiting
signaling pathways in the pathogenesis of peritoneal adhesions
subsequently resulting in increased adhesion formation. Under-
standing of the impact of genetic and constitutional factors on
adhesion formation allows us to suggest some basic principles of
a personalized adhesion formation strategy (see Fig. 1). Therefore.
Fig. 1. A personalized adhesion prevention strategy with targeted elimination, inhibi-
tion and/or interlocking of coexisting adhesion initiating factors of postsurgical acute
inﬂammation and wound healing.
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ual coexisting factors prior to surgery.1. Genetic predisposition factors
Recent ﬁndings support a hypothesis that, in some individuals,
an increased adhesion formation is associated with a genetic pre-
disposition. Hence it was shown that an increased risk for adhesion
formation is found in carriers of IL-1RN*2 allele [10].
On the other hand Tulandi et al. [11] presented an increased
adhesion rate between the uterus and the bladder and between
the uterus and the abdominal wall among women with keloid
scarring (KS) after Cesarean section. These ﬁndings correspond
with results supporting a strong genetic predisposition of some
individuals to KS [12]. Then, a comparative genomic hybridiza-
tion analysis of KS suggests a possible involvement of HLA class
II histocompatibility antigen (HLA-DRB5) in a pathogenesis of
KS [13].
Luo et al. [14] found an overexpression of a higher number of
apoptotic-related genes in samples of KS and incisional scars, sug-
gesting an increased rate of cellular turnover. Subsequently,
apoptotic and non-apoptotic cell death is considered to increase
local inﬂammatory reaction and is supposed to be a key step in tis-
sue ﬁbrosis. A number of genes functionally categorized as pro-in-
ﬂammatory and pro-ﬁbrotic mediators were identiﬁed in both KS
and incisional scars [14]. These ﬁndings correlate with results of
in vitro experiments which demonstrate that a microarray analysis
of adhesions identiﬁes speciﬁc genes with increased and decreased
expression when compared with a normal peritoneum [15].
Many studies have addressed this issue by exploring novel bio-
markers, genes, proteins, cytokines and mediators possibly
involved in peritoneal adhesions [16e19]. It may help us gain
more insight into the mechanisms of adhesion formation and sug-
gest hypotheses and concepts taking into account signaling path-
ways based on the new ﬁndings [20,21].
Recentlyawayof geneticmanipulation topreventpostsurgical ad-
hesions was presented in a cell-culturemodel bymodiﬁcations of re-
porter gene expression in human adhesion ﬁbroblasts [22]. The
adenovirusvectorwasdesignedto support thehighest level of recom-
binant tissueplasminogenactivator (rtPA)expression inhumanadhe-
sion cells withminimal scarring [22] and this approach seems to be a
promising adhesion prevention strategy for future studies.2. Constitutional predisposition factors
Although many clinical observations have shown the impact of
body mass index (BMI) on postsurgical outcome, recent studies
examining the impact of obesity on outcomes of endoscopic proce-
dures and several systemic reviews have yielded conﬂicting results.
Concerning the type of surgical procedures at the beginning of
the “endoscopic era” complication rates for laparoscopic surgery
(LS) on massively obese patients were higher than in the general
population undergoing LS [23], then obesity was questioned as a
high-risk factor for laparoscopic colorectal surgery [24]. Further
studies of laparoscopic approach have shown that obese patients
who are thought to be at increased risk of postoperative morbidity
have the similar beneﬁt as non-obese patients with colorectal [25]
and gynecologic diseases [26].
However Siedhoff et al. [27] based on the retrospective cohort
study including 834 patients who underwent laparoscopic hys-
terectomy, suggested that there is a signiﬁcant association of
BMI with surgical outcomes, and the effect is most pronounced
in the morbidly obese ones. Akiyoshi et al. [28] found that the
rate of postoperative complications was signiﬁcantly higher in
obese II patients than both in non-obese and obese I patients.
Multivariate analysis showed that a BMI in the obese II range
was an independent predictive factor for developing anastomotic
leakage. Whereas, Mustain et al. [29] in their retrospective anal-
ysis of 9693 patients found signiﬁcant differences among BMI
classes for length of stay, operative time, and wound complica-
tion and conﬁrmed that obesity is an independent risk factor
for wound complications in patients undergoing laparoscopic
colectomy.
An increased risk of wound infection complications has been
conﬁrmed in many studies, however an impact of BMI on adhesion
formation was presented only by postmortem analysis [30]. By
analyzing of 752 autopsies, Weibel and Majno [30] showed that
the chances of postoperative adhesions developing are greater for
a heavy woman if that woman is relatively short. Subsequently
they concluded that as regards constitutional factors, short women
who were also obese were especially prone to postoperative adhe-
sions. These ﬁndings were contradicted with the existing, at that
period predominant theory, that ‘asthenic’ individuals are more
prone to the development of adhesions. Although the authors sug-
gested that “large amounts of fatty tissue make the surgical proce-
dure more difﬁcult, longer, and more traumatizing, especially if the
patient is relatively short” [30] unfortunately their concept was not
evaluated.
Long ago a retrospective analysis was done as part of ScD thesis
aiming to determine a relationship between BMI and pelvic adhe-
sion extension rate (PAER) among 1152 women of reproductive
age [31]. All patients had undergone prior surgeries, and then pelvic
adhesions were evaluated during repeated surgery according to the
pelvic adhesion classiﬁcation system. Pelvic adhesions were
deﬁned as PAER 0 e absence of adhesions; PAER I degree e a few
and light pelvic adhesions; PAER II degree e multiple, light and
ﬂat non vascularized pelvic adhesions and invisible <50% part of
adnexa and/or uterus; PAER III degree e multiple, density, thick
and vascularized pelvic adhesions and invisible >50% part of
adnexa and/or uterus; PAER IV degree e multiple, density, thick
and vascularized pelvic adhesions and invisible adnexa and/or
uterus at all or “frozen pelvis”. Brieﬂy, 831 patients had experienced
prior laparotomy and 221 patients e laparoscopic procedures. 49
patients had undergone only diagnostic procedures, whereas
1103 patientse various gynecological procedures or Caesarean sec-
tions. The total number of repeated surgical procedures was esti-
mated at up to 14 and the fraction of prior single surgical
procedures amounted to 57.8% in patients without adhesions,
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50.0, 47.2, 44.2 and 39.0% in patients respectively with PAER I, II,
III and IV. Therewas a direct positive correlation between increased
weigh value and the PAER. Overweight was accompanied by an
elevated PAER. On the contrary, therewas a negative correlation be-
tween height and the PAER. Subsequently, increased height was
accompanied by a reduced PAER [31,32].
Our previous results [31] are in accord with the postmortem
data by Weibel & Majno [30] thereby supporting our current
concept of personalized adhesion prevention strategy. Howev-
er, in both of these studies surgical procedures had been per-
formed in the past and the patient's weight was not known at
the time of prior surgery, which is the main limiting factor.
Therefore taking into account the limitations of these studies
we suggest that the impact of BMI on postoperative adhesion
formation calls for further investigations by prospective ran-
domized studies with anthropometric patient parameters dur-
ing initial surgery.
A possible impact of the obesity metabolism on adhesion forma-
tion can be linked by recent experimental studies which presented
remarkable dysfunctions of macrophages caused by hyperglycemia
and insulin deﬁciency, to which patients with diabetes are highly
susceptible [33]. Macrophages were suggested to be a fundamental
factor in triggering postsurgical adhesions [34e36], by the expres-
sion of pro-inﬂammatory cytokines.
In non-English literature, several genetic and constitutional con-
ditions were suggested as increased adhesion predisposing factors,
including so-called ‘dense-vascularised’ peritoneal adhesions
formulated by an Italian team as “The simultaneous combination
of high levels of exogenous female hormones (hormone replace-
ment therapy or prolonged exposure to oral contraceptives) or
endogenous hormones (as happens during pregnancy), a genetic
predisposition (including genetic malformations) and previous sur-
gery (peritoneal trauma), as evidenced in our patients, all seem to
play a key role in the pathogenesis of so-called ‘dense-vascularised’,
particularly tenacious adhesions responsible for the activation of
multipotent mesenchymal submesothelial peritoneal cells” [37].
Many Russian researchers showed a rapid acetylation phenotype
to be a pre-surgery screening-test for the prediction of the risk of
postoperative adhesive complications and the need for preventive
treatment [38,39].
Therefore, screening and diagnostic procedures may explore
these individual coexisting factors prior to surgery such as in the
PAPA- pilot study [40]. According to these ﬁndings, a personalized
adhesion prevention strategy with targeted predisposing genetic
and constitutional conditions, e.g., recommendations to decrease
concentration of homocysteine, vitamin supplementations, folic
acid, etc., may exclude or decrease the impact of these coexisting
factors on acute inﬂammation and wound healing (see Fig. 1).
Standardized surgical procedures will be done with or without
adhesion prevention depending on the individual predisposing
condition of a given patient. Targeted postsurgical adhesion pre-
vention may be implicated depending on an individual predispos-
ing condition e.g., medication to increase local tPA [41], inhibit
local PAI-1 [42], induce ﬁbroblast apoptosis [43], and down regulate
collagen cross linking [44,45], changing functional phenotype of
peritoneal macrophages [46], local immunosuppression [20], appli-
cation of genetic technologies [21,22] etc. In this case it is not neces-
sary to use adhesion prevention barriers or other adjuvants in
individuals with inhibited genetic and/or constitutional coexisting
factors, when standardized minimally invasive surgical procedures
were done.
It is important to emphasize that whenever surgical procedures
are performed, both in adhesion high and low risk cases, a good
practice is to prevent adhesions by a standardized surgicaltechnique and simple measurements avoiding iatrogenic ‘adhesio-
genic’ well-known factors such as use of towels, unnecessary
manual intervention, excessive tissue trauma by electro/thermal
coagulation and suturing, etc.
In conclusion, today we are at the beginning of a new era in
medicine. In the near future upon accumulating evidence of ge-
netic and constitutional predisposing factors by the-state-of-
the-art screening and diagnostic tools and the reduction in
price of these technologies, this strategy will become the domi-
nating management strategy of postoperative adhesion
prevention.
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